X0303 4 2009-06-30 0 0001339455 Somaxon Pharmaceuticals, Inc. SOMX 0001024004 HALE DAVID F C/O SOMAXON PHARMACEUTICALS 3830 VALLEY CENTRE DRIVE, SUITE 705-461 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2009-06-30 4 A 0 12030 0.00 A 235430 I By Hale Family Trust UTD 2/10/86 Common Stock 228107 I By Hale Family Trust UTD 2/10/86 These shares are represented by restricted stock units ("RSUs"). These RSUs will vest upon the first date included within an open trading window under the Company's Insider Trading Policy following the first commercial sale of Silenor(R) in the United States, subject to the Reporting Person's continued service to the Company on such date. Pursuant to an Equity Award Transfer Agreement dated June 30, 2009, all RSUs previously held by Reporting Person directly and all outstanding stock options held by Reporting Person were transferred to the Hale Family Trust UTD 2/10/86. /s/ Matthew Onaitis, Attorney-in-fact 2009-07-02